Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Christina Cox

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Investigational New Drugs|January 17, 2025
Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Arianna Bandini, et al.
Scandinavian Journal of Infectious Diseases|June 24, 2011
Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: a case reportPaola Begini, Maria Christina Cox, Stefano Angeletti, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 9, 2019
Relapsing Long-Lasting Garcin Syndrome Revealing Skull Base Diffuse B Cell Lymphoma: The Diagnosis through the "Hartel's Route"Barbara Casolla, Serena Candela, Antonio Ciacciarelli, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 23, 2003
Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patientsMaria Christina Cox, Paola Panetta, Adriano Venditti, et al.
World Journal of Gastrointestinal Oncology|April 3, 2012
Patients with hematological malignancies and serological signs of prior resolved hepatitis BMassimo Marignani, Elia Gigante, Paola Begini, et al.
World Journal of Gastrointestinal Oncology|April 3, 2012
HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questionsMaria Christina Cox, Maria Antonietta Aloe-Spiriti, Elena Cavalieri, et al.
Cancers|January 28, 2026
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective AnalysisSabrina Pelliccia, Marta Banchi, Lucrezia De Marchi, et al.
Tumori|October 12, 2012
Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectumVitaliana De Sanctis, Massimo Marignani, Stefano Angeletti, et al.
British Journal of Haematology|July 13, 2010
Specific effects exerted by B-lymphoproliferative diseases on peripheral T-lymphocyte protein expressionMarina Borro, Giovanna Gentile, Ottavia De Luca, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2019
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccineCaterina Lapenta, Simona Donati, Francesca Spadaro, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|January 17, 2025
Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathwayMarta Banchi, Maria Christina Cox, Arianna Bandini, et al.
Scandinavian Journal of Infectious Diseases|June 24, 2011
Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: a case reportPaola Begini, Maria Christina Cox, Stefano Angeletti, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 9, 2019
Relapsing Long-Lasting Garcin Syndrome Revealing Skull Base Diffuse B Cell Lymphoma: The Diagnosis through the "Hartel's Route"Barbara Casolla, Serena Candela, Antonio Ciacciarelli, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 23, 2003
Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patientsMaria Christina Cox, Paola Panetta, Adriano Venditti, et al.
World Journal of Gastrointestinal Oncology|April 3, 2012
Patients with hematological malignancies and serological signs of prior resolved hepatitis BMassimo Marignani, Elia Gigante, Paola Begini, et al.
World Journal of Gastrointestinal Oncology|April 3, 2012
HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questionsMaria Christina Cox, Maria Antonietta Aloe-Spiriti, Elena Cavalieri, et al.
Cancers|January 28, 2026
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective AnalysisSabrina Pelliccia, Marta Banchi, Lucrezia De Marchi, et al.
Tumori|October 12, 2012
Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectumVitaliana De Sanctis, Massimo Marignani, Stefano Angeletti, et al.
British Journal of Haematology|July 13, 2010
Specific effects exerted by B-lymphoproliferative diseases on peripheral T-lymphocyte protein expressionMarina Borro, Giovanna Gentile, Ottavia De Luca, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2019
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccineCaterina Lapenta, Simona Donati, Francesca Spadaro, et al.
Pageof 6